Home NLS Pharmaceutics

NLS Pharmaceutics

In operation
Post-IPO Round
Innovative Therapies Developer for Central Nervous System Diseases

Basic Information

NLS Pharmaceutics is an innovative therapy developer focused on rare and complex central nervous system disorders. Led by an experienced management team, it has a strong track record in the development and repurposing of candidate products to treat rare and complex CNS conditions. The R&D focus is based on a robust scientific understanding of neurobehavioral and neurocognitive disorders and their pharmacology. We believe our patient-centered approach enhances success rates, and our successful collaborations with experts from industry and academia allow for targeted and tailored methods.
NLS Pharmaceutics, Ltd.
Stans,Nidwalden,Switzerland
15~50 people
January 01, 2015
contact@nls-pharma.com